| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | -4.76% | +0.66% | -5.42% | -5.42% | — |
| 14d | 1 | +0.00% | -7.54% | -0.37% | -7.17% | -7.17% | — |
| 30d | 1 | +0.00% | -3.97% | -3.38% | -0.59% | -0.59% | — |
| 60d | 1 | +100.00% | +7.94% | +4.00% | +3.94% | +3.94% | — |
| 90d | 1 | +0.00% | -5.55% | +8.71% | -14.26% | -14.26% | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASE SVP, Regulatory Affairs | 1,000 | $1.27 | $1.3K | 1,012 | Feb 17, 2026 | Mar 17, 2026 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 9,000 | — | — | 9,000 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 8,000 | — | — | 8,000 | Jan 13, 2025 | Jan 14, 2025 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Jan 4, 2024 | Jan 5, 2024 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | Jan 3, 2023 | Jan 5, 2023 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 15,000 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASE Senior Vice President | 19,512 | — | — | 48,186 | Aug 17, 2021 | Aug 17, 2021 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | SALE Senior Vice President | 100,000 | — | — | 0 | Aug 17, 2021 | Aug 17, 2021 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASE Senior Vice President | 4,878 | — | — | 53,064 | Aug 17, 2021 | Aug 17, 2021 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | SALE Senior Vice President | 400,000 | — | — | 0 | Aug 17, 2021 | Aug 17, 2021 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASE Senior Vice President | 9,162 | — | — | 28,674 | Aug 17, 2021 | Aug 17, 2021 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | SALE Senior Vice President | 61,821 | — | — | 0 | Aug 17, 2021 | Aug 17, 2021 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | SALE Senior Vice President | 280,000 | — | — | 0 | Aug 17, 2021 | Aug 17, 2021 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | SALE Senior Vice President | 100,000 | — | — | 0 | Aug 17, 2021 | Aug 17, 2021 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | SALE Senior Vice President | 357,142 | — | — | 0 | Aug 17, 2021 | Aug 17, 2021 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASE Senior Vice President | 13,658 | — | — | 84,143 | Aug 17, 2021 | Aug 17, 2021 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASE Senior Vice President | 4,878 | — | — | 4,878 | Aug 17, 2021 | Aug 17, 2021 ↗ | View → |
| DRMA DERMATA THERAPEUTICS, INC. | PURCHASE Senior Vice President | 17,421 | — | — | 70,485 | Aug 17, 2021 | Aug 17, 2021 ↗ | View → |